Flinton Capital Management’s Zimmer Biomet ZBH Stock Holding History

Flinton Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.12M	Sell	8,370 -1,506	-15%	-$195K	0.03%	299
2019 Q2	$1.13M	Sell	9,876 -2,801	-22%	-$328K	0.04%	306
2019 Q1	$1.57M	Buy	12,677 +1,506	+13%	+$171K	0.05%	237
2018 Q4	$1.13M	Sell	11,171 -1,016	-8%	-$114K	0.04%	255
2018 Q3	$1.56M	Sell	12,187 -630	-5%	-$74.9K	0.05%	249
2018 Q2	$1.39M	Buy	12,817 +945	+8%	+$103K	0.04%	266
2018 Q1	$1.26M	Buy	11,872 +245	+2%	+$28.5K	0.04%	256
2017 Q4	$1.36M	Buy	11,627 +1,611	+16%	+$182K	0.05%	244
2017 Q3	$1.14M	Buy	10,016 +280	+3%	+$32.3K	0.04%	253
2017 Q2	$1.21M	Sell	9,736 -70	-0.7%	-$8.3K	0.04%	244
2017 Q1	$1.16M	Buy	9,806 +1,086	+12%	+$123K	0.04%	246
2016 Q4	$874K	Buy	+8,720	New	+$935K	0.04%	251

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Flinton Capital Management's ZBH Position: Q3 2019 in Review

Flinton Capital Management reduced its Zimmer Biomet (ZBH) stake by 15% in Q3 2019, selling an estimated $195K and leaving 8,370 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #299.

Flinton Capital Management first reported a position in ZBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.57M in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Flinton Capital Management held 8,370 shares of Zimmer Biomet worth $1.12M as of Q3 2019.
Flinton Capital Management sold 1,506 Zimmer Biomet shares in Q3 2019, an estimated $195K.
Zimmer Biomet made up 0.03% of Flinton Capital Management's portfolio in Q3 2019, its #299 holding.
Flinton Capital Management first reported a position in Zimmer Biomet in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Zimmer Biomet position peaked at $1.57M in Q1 2019.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.